These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 29436696)
1. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. Benedicto A; Romayor I; Arteta B Oncol Rep; 2018 Apr; 39(4):2022-2030. PubMed ID: 29436696 [TBL] [Abstract][Full Text] [Related]
2. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer. Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725 [No Abstract] [Full Text] [Related]
3. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development. Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187 [No Abstract] [Full Text] [Related]
4. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3. Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563 [No Abstract] [Full Text] [Related]
5. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030 [TBL] [Abstract][Full Text] [Related]
6. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments. Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540 [TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma. Xu Y; Fang F; Jiao H; Zheng X; Huang L; Yi X; Zhao W Cancer Immunol Immunother; 2019 Dec; 68(12):1959-1969. PubMed ID: 31641797 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662 [TBL] [Abstract][Full Text] [Related]
9. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer. Ma L; Qiao H; He C; Yang Q; Cheung CH; Kanwar JR; Sun X Invest New Drugs; 2012 Apr; 30(2):508-17. PubMed ID: 21080209 [TBL] [Abstract][Full Text] [Related]
10. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB; Zhao ZF; Zhou X J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000 [TBL] [Abstract][Full Text] [Related]
11. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro. Liu Y; Ren CC; Yang L; Xu YM; Chen YN J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455 [TBL] [Abstract][Full Text] [Related]
13. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model. Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814 [TBL] [Abstract][Full Text] [Related]
14. Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy. Chaudary N; Pintilie M; Jelveh S; Lindsay P; Hill RP; Milosevic M Clin Cancer Res; 2017 Mar; 23(5):1242-1249. PubMed ID: 27697997 [No Abstract] [Full Text] [Related]
15. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. Ray P; Lewin SA; Mihalko LA; Schmidt BT; Luker KE; Luker GD Neoplasia; 2011 Dec; 13(12):1152-61. PubMed ID: 22241961 [TBL] [Abstract][Full Text] [Related]
16. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Domanska UM; Timmer-Bosscha H; Nagengast WB; Oude Munnink TH; Kruizinga RC; Ananias HJ; Kliphuis NM; Huls G; De Vries EG; de Jong IJ; Walenkamp AM Neoplasia; 2012 Aug; 14(8):709-18. PubMed ID: 22952424 [TBL] [Abstract][Full Text] [Related]
17. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment. Zeng Y; Li B; Liang Y; Reeves PM; Qu X; Ran C; Liu Q; Callahan MV; Sluder AE; Gelfand JA; Chen H; Poznansky MC FASEB J; 2019 May; 33(5):6596-6608. PubMed ID: 30802149 [TBL] [Abstract][Full Text] [Related]
18. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. Sorrentino C; Miele L; Porta A; Pinto A; Morello S Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504 [TBL] [Abstract][Full Text] [Related]
19. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model. Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655 [TBL] [Abstract][Full Text] [Related]
20. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Daniel SK; Seo YD; Pillarisetty VG Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]